MRK.TO Merck CDR (CAD Hedged)

Healthcare Drug Manufacturers - General Toronto Exchange
- CAD
Market cap
-
P/E
147.9x
P/B
7.91x
ROE
-1.5%
Dividend yield
2.67%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is MRK.TO undervalued?

Graham number

The Graham number of Merck CDR (CAD Hedged) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Merck CDR (CAD Hedged) fundamental analysis

No fundamental analysis for Merck CDR (CAD Hedged) yet.

Merck CDR (CAD Hedged) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Merck CDR (CAD Hedged)

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and …

Full company profile